Drug recall: 55,000 bottles of Colchicine tablets due to this reason

An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine, it added.

573

Last Updated on December 31, 2023 by The Health Master

New Delhi: Drug firm Zydus Lifesciences is recalling over 55,000 bottles of generic medication in the US market due to failed impurities specifications.

As per the latest enforcement report by the US Food and Drug Administration (USFDA), Zydus Pharmaceuticals (USA) Inc is recalling 21,936 (30 count) and 33,096 (100 count) bottles of Colchicine tablets, which are used to treat gout.

The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.

USFDA said the company is recalling the product due to “failed impurities/ degradation specifications”.

An out-of-specification (OOS) result was observed during release testing of one lot for a related substance, i.e. Beta-lumicolchicine, it added.

Zydus commenced the Class III recall on February 24 this year.

As per the USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.

The US market is the largest market for generic pharmaceutical products. The market was estimated to be around USD 115.2 billion in 2019.

Drug recall: Brimonidine Tartrate Ophthalmic Solution recalled due to this reason

Drug recall: 4,000 bottles of Tacrolimus Capsules recalled due to this reason

Drug recall: Artificial Tears Lubricant Eye Drops recalled due to this reason

Drug recall: 3,665 Bottles of this antifungal drug recalled due to this reason

Drug recall: Over 34,000 bottles of Diltiazem HCL capsules recalled due to this reason

Drug recall: 5,720 tubes of Clobetasol Propionate Cream recalled due to this reason

USFDA gives approval for this Antifungal drug

Drug Control Dept launches WhatsApp helpline number: Tamil Nadu

Proposal to regulate prices of non-scheduled drugs under consideration

Govt Job: For B.Pharm as Bench Chemist at CDSCO

USFDA issues Form 483 with 2 observations to Alembic, Gujarat

West Bengal notice to Pharma Industry on bio-resource use

Difference: Disintegration and Dissolution test in pharma industry

How to prepare SOPs in the Pharma Industry

Difference between branded and generic medicines

Understanding DQ, IQ, PQ, and OQ in the Pharma Industry

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon

For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:

YouTube Icon

For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:

YouTube Icon

For informative videos on consumer awareness, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news